Overview

Study of Ocular Penetration of Topically Administered Fluoroquinolones

Status:
Completed

Trial end date:
2009-11-01

Target enrollment:

Participant gender:

Summary

This study is being conducted to evaluate the intraocular penetration of Moxifloxacin 0.5% ophthalmic solution (Vigamox) and Besifloxacin 0.6% ophthalmic suspension (Besivance) after pre-operative topical administration in subjects undergoing cataract surgery.

Phase:

Phase 4

Details

Lead Sponsor:

Johns Hopkins University

Treatments:

7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Besifloxacin
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ophthalmic Solutions